UBS AM
VRN

UBS AM’s Veren VRN Stock Holding History

UBS AM’s Portfolio VRN Stock Details VRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-543,452
Closed -$3.6M – 2728
2025
Q1 		$3.6M Buy
543,452
+172,641
+47% +$955K ﹤0.01% 1726
2024
Q4 		$1.91M Sell
370,811
-168,258
-31% -$924K ﹤0.01% 2070
2024
Q3 		$3.32M Sell
539,069
-67,383
-11% -$482K ﹤0.01% 1781
2024
Q2 		$4.77M Buy
+606,452
New +$5.11M ﹤0.01% 1517
2022
Q2 		– Sell
-613,839
Closed -$4.45M – 2785
2022
Q1 		$4.45M Sell
613,839
-130,289
-18% -$880K ﹤0.01% 1410
2021
Q4 		$3.98M Sell
744,128
-36,285
-5% -$177K ﹤0.01% 1523
2021
Q3 		$3.6M Sell
780,413
-63,676
-8% -$235K ﹤0.01% 1522
2021
Q2 		$3.82M Buy
844,089
+25,955
+3% +$109K ﹤0.01% 1504
2021
Q1 		$3.41M Sell
818,134
-87,450
-10% -$309K ﹤0.01% 1516
2020
Q4 		$2.11M Sell
905,584
-232,573
-20% -$398K ﹤0.01% 1661
2020
Q3 		$1.37M Buy
1,138,157
+131,690
+13% +$214K ﹤0.01% 1709
2020
Q2 		$1.63M Buy
1,006,467
+156,135
+18% +$216K ﹤0.01% 1599
2020
Q1 		$651K Sell
850,332
-20,212
-2% -$55.9K ﹤0.01% 1868
2019
Q4 		$3.89M Buy
870,544
+65,127
+8% +$255K ﹤0.01% 1296
2019
Q3 		$3.44M Buy
805,417
+12,287
+2% +$42.6K ﹤0.01% 1362
2019
Q2 		$2.63M Sell
793,130
-28,385
-3% -$102K ﹤0.01% 1451
2019
Q1 		$2.66M Sell
821,515
-6,986
-0.8% -$21.5K ﹤0.01% 1387
2018
Q4 		$2.51M Sell
828,501
-1,103,980
-57% -$4.7M ﹤0.01% 1337
2018
Q3 		$12.3M Sell
1,932,481
-161,266
-8% -$1.06M 0.01% 884
2018
Q2 		$15.4M Buy
2,093,747
+155,665
+8% +$1.23M 0.01% 835
2018
Q1 		$13.2M Buy
1,938,082
+466,383
+32% +$3.54M 0.01% 860
2017
Q4 		$11.3M Buy
1,471,699
+27,163
+2% +$205K 0.01% 894
2017
Q3 		$11.6M Buy
1,444,536
+35,533
+3% +$260K 0.01% 870
2017
Q2 		$10.8M Sell
1,409,003
-43,074
-3% -$403K 0.01% 888
2017
Q1 		$15.6M Buy
1,452,077
+772
+0.1% +$8.96K 0.02% 790
2016
Q4 		$19.8M Buy
1,451,305
+240,536
+20% +$3.08M 0.02% 683
2016
Q3 		$15.9M Buy
1,210,769
+57,165
+5% +$853K 0.02% 759
2016
Q2 		$18.1M Sell
1,153,604
-34,936
-3% -$560K 0.02% 714
2016
Q1 		$16.5M Buy
1,188,540
+56,876
+5% +$657K 0.02% 725
2015
Q4 		$13.1M Sell
1,131,664
-73,717
-6% -$969K 0.02% 803
2015
Q3 		$13.7M Buy
1,205,381
+120,428
+11% +$1.69M 0.02% 788
2015
Q2 		$22M Sell
1,084,953
-97,746
-8% -$2.29M 0.02% 690
2015
Q1 		$25.6M Sell
1,182,699
-654,369
-36% -$14.9M 0.02% 633
2014
Q4 		$40.5M Sell
1,837,068
-78,633
-4% -$2.14M 0.04% 483
2014
Q3 		$64.1M Buy
1,915,701
+432,420
+29% +$16M 0.06% 325
2014
Q2 		$60.2M Buy
1,483,281
+76,879
+5% +$2.86M 0.06% 338
2014
Q1 		$47M Buy
+1,406,402
New +$45.4M 0.05% 395

Other funds holding VRN

PM
Penbrook Management New York $132M AUM 29.91% 1-Year Est. Return
OLVIG
Oliver Lagore Vanvalin Investment Group Flint, Michigan $255M AUM

UBS AM's VRN Position: Q2 2025 in Review

UBS AM sold out of Veren (VRN) in Q2 2025, closing a stake of 543,452 shares — an estimated $3.6M sold.

UBS AM first reported a position in VRN in Q1 2014 and held it in 37 quarters. The position peaked at $64.1M in Q3 2014. 2 funds tracked by Wall St. Rank hold VRN as of Q2 2025.

  • UBS AM reported no remaining Veren position as of Q2 2025 after selling out during the quarter.
  • UBS AM sold 543,452 Veren shares in Q2 2025, an estimated $3.6M.
  • UBS AM first reported a position in Veren in Q1 2014 and held it in 37 quarters.
  • UBS AM's Veren position peaked at $64.1M in Q3 2014.
  • 2 funds tracked by Wall St. Rank held Veren as of Q2 2025.

Based on UBS AM's 13F filing for Q2 2025, filed 14 Aug 2025.